Cambrex Corporation is a life sciences company that supplies products and services to accelerate therapeutic discovery, development and manufacturing. Life sciences products and services contribute approximately 80% of the Company's gross profit. The Rutherford Chemicals segment makes up the balance. Cambrex provides pharmaceutical ingredients, intermediates and services to drug companies using biological and chemical platforms. For the biotherapeutic market, Cambrex supplies serum-free media and media optimization, bioprocess development, scale-up and manufacturing services and is becoming a strategic partner with companies involved with cell therapy. To the bioresearch market, it provides tools for DNA, RNA and protein separation and sequencing, cell-based bioassays for toxicology testing, and normal human cells. The Rutherford Chemicals segment includes animal feed additives and fine chemicals used in herbicides and insecticides and products sold to a variety of niche markets.